Metraipolis › archive › dc_87977a597ca2

Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42923586
DOI
10.1210/jcemcr/luag249
License (as archived)
solo-consultazione
Archived
2026-11-01T06:44:38.687Z
SHA-256 of the archived text
d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3
Stable URL of this page
https://metraipolis.com/documento/dc_87977a597ca2

How to cite

Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586 — Europe PMC (en), https://europepmc.org/article/MED/42923586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_87977a597ca2 (Metraipolis archive dc_87977a597ca2, sha256 d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3)
BibTeX
@misc{dc87977a597ca2,
  title = {Tocilizumab in refractory pretibial myxedema: new therapeutic insights — Europe PMC PMID:42923586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42923586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_87977a597ca2; sha256 d20f5173aa94ecf2d216e330cafb6ef040eb5b5a0ab8c31bf0c60220cb94f5c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42923586. Agents can read the archived copy with the MCP tool read_document.